Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05695430 · ClinicalTrials.gov registry record · NA
Brief Cognitive Behavioral Therapy for People With Physical Disabilities
A NA study of Suicide and Suicidal Ideation, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05695430: Recruiting NA study of Suicide and Suicidal Ideation, sponsored by Ohio State University.
NCT05695430 is a NA study of Suicide and Suicidal Ideation that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 60 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05695430, a NA study of Suicide and Suicidal Ideation, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effectiveness of a psychotherapy (non-medication) treatment, Brief Cognitive Behavioral Therapy for Suicide Prevention, in reducing suicide ideation and attempts for people with physical disabilities.
Primary Outcome
Past-week suicidal ideation severity
Conditions Studied
Interventions
- BEHAVIORAL Brief Cognitive Behavioral Therapy for People with Physical Disabilities
Study Locations (1)
Ohio
- The Ohio State Universitty Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT05695430 shows while recruiting
NCT05695430 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower).
The record links to 6 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Brief Cognitive Behavioral Therapy for People with Physical Disabilities is the first listed.
NCT05695430 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05695430 about?
NCT05695430 is a clinical study titled "Brief Cognitive Behavioral Therapy for People With Physical Disabilities". The purpose of this study is to examine the effectiveness of a psychotherapy (non-medication) treatment, Brief Cognitive Behavioral Therapy for Suicide Prevention, in reducing suicide ideation and attempts for people with physical disabilities.
What is the current status of trial NCT05695430?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-03-01. Estimated completion is 2026-03.
What conditions does trial NCT05695430 study?
This clinical trial studies the following conditions: Suicide, Suicidal Ideation, Suicide, Attempted, Disability Physical, Disability Hearing.
What interventions are being tested in trial NCT05695430?
The interventions under investigation include: Brief Cognitive Behavioral Therapy for People with Physical Disabilities (BEHAVIORAL).
Who is sponsoring clinical trial NCT05695430?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05695430 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05695430's enrollment target sits among peer trials
60 66th of 92 higher than 25 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI